November 15, 2026
Breaking
Business

Alembic Pharma receives USFDA approval for lung cancer drug Binimetinib

admin1 min read

The approved Abbreviated New Drug Application (ANDA) is therapeutically equivalent to the reference listed drug product, Mektovi Tablets (15 mg), of Array BioPharma Inc

The post Alembic Pharma receives USFDA approval for lung cancer drug Binimetinib appeared first on Home Page.

Leave a Comment

Your email address will not be published. Required fields are marked *